On Thursday 22nd October, our Co-founder and CEO Alexander Seyf will be presenting at the AusBiotech Annual Conference as part of the session “From Lab to Impact: Rethinking Health Innovation for Adoption and Scale.”

The discussion will examine how Australia can move beyond innovation for novelty alone toward innovation that delivers measurable impact. Alexander will highlight and discuss the benefits of digitisation and automation in advanced therapy manufacturing, including fewer manual errors, faster batch review, lower costs and more scalable, traceable operations. Autolomous supports this with autoloMATE®, a digitised end-to-end solution for manufacturing management.

The session runs from 2:35pm to 3:20pm AEST at the Gold Coast Convention and Exhibition Centre, Australia. If you’re attending, come along, and if you’d like to connect with the Autolomous team during the conference, please get in touch.